251 related articles for article (PubMed ID: 32964051)
1. Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome.
Huerta-Delgado AS; Roffe-Vazquez DN; Gonzalez-Gil AM; Villarreal-Calderón JR; Tamez-Rivera O; Rodriguez-Gutierrez NA; Castillo EC; Silva-Platas C; Garcia-Rivas G; Elizondo-Montemayor L
J Diabetes Res; 2020; 2020():1949415. PubMed ID: 32964051
[TBL] [Abstract][Full Text] [Related]
2. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus.
Elizondo-Montemayor L; Gonzalez-Gil AM; Tamez-Rivera O; Toledo-Salinas C; Peschard-Franco M; Rodríguez-Gutiérrez NA; Silva-Platas C; Garcia-Rivas G
Mediators Inflamm; 2019; 2019():6737318. PubMed ID: 31015797
[TBL] [Abstract][Full Text] [Related]
3. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.
Rana KS; Pararasa C; Afzal I; Nagel DA; Hill EJ; Bailey CJ; Griffiths HR; Kyrou I; Randeva HS; Bellary S; Brown JE
Cardiovasc Diabetol; 2017 Nov; 16(1):147. PubMed ID: 29121940
[TBL] [Abstract][Full Text] [Related]
4. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
5. Increased irisin versus reduced fibroblast growth factor1 (FGF1) in relation to adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes.
Saber GY; Kasabri V; Saleh MI; Suyagh M; Halaseh L; Jaber R; Abu-Hassan H; Alalawi S
Horm Mol Biol Clin Investig; 2019 Mar; 38(1):. PubMed ID: 30840586
[TBL] [Abstract][Full Text] [Related]
6. Circulating irisin in relation to insulin resistance and the metabolic syndrome.
Park KH; Zaichenko L; Brinkoetter M; Thakkar B; Sahin-Efe A; Joung KE; Tsoukas MA; Geladari EV; Huh JY; Dincer F; Davis CR; Crowell JA; Mantzoros CS
J Clin Endocrinol Metab; 2013 Dec; 98(12):4899-907. PubMed ID: 24057291
[TBL] [Abstract][Full Text] [Related]
7. Lower circulating irisin is associated with type 2 diabetes mellitus.
Liu JJ; Wong MD; Toy WC; Tan CS; Liu S; Ng XW; Tavintharan S; Sum CF; Lim SC
J Diabetes Complications; 2013; 27(4):365-9. PubMed ID: 23619195
[TBL] [Abstract][Full Text] [Related]
8. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
9. Irisin is a biomarker for metabolic syndrome in prepubertal children.
Shim YS; Kang MJ; Yang S; Hwang IT
Endocr J; 2018 Jan; 65(1):23-31. PubMed ID: 28904307
[TBL] [Abstract][Full Text] [Related]
10. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents.
Yin C; Hu W; Wang M; Lv W; Jia T; Xiao Y
Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):320-329. PubMed ID: 31740239
[TBL] [Abstract][Full Text] [Related]
11. Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome.
Slate-Romano JJ; Yano N; Zhao TC
Mol Cell Endocrinol; 2022 Jul; 552():111676. PubMed ID: 35569582
[TBL] [Abstract][Full Text] [Related]
12. Obese with higher FNDC5/Irisin levels have a better metabolic profile, lower lipopolysaccharide levels and type 2 diabetes risk.
Bonfante ILP; Chacon-Mikahil MPT; Brunelli DT; Gáspari AF; Duft RG; Oliveira AG; Araujo TG; Saad MJA; Cavaglieri CR
Arch Endocrinol Metab; 2017 Dec; 61(6):524-533. PubMed ID: 29412381
[TBL] [Abstract][Full Text] [Related]
13. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
14. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus.
El-Lebedy DH; Ibrahim AA; Ashmawy IO
Diabetes Metab Syndr; 2018 Sep; 12(5):643-648. PubMed ID: 29673927
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum levels of Irisin as a marker of endothelial dysfunction in patients with type 2 diabetes mellitus.
Ahmed TM; Nassar M; Mohamed HAA; Elhadidy KE; Farhan HM; El Basset ASA; Elmessiery RM; Kamel MF
Endocrinol Diabetes Metab; 2023 May; 6(3):e403. PubMed ID: 36919265
[TBL] [Abstract][Full Text] [Related]
16. [Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population].
Guzmán-Guzmán IP; Zaragoza-García O; Vences-Velázquez A; Castro-Alarcón N; Muñoz-Valle JF; Parra-Rojas I
Med Clin (Barc); 2016 Nov; 147(10):427-434. PubMed ID: 27576535
[TBL] [Abstract][Full Text] [Related]
17. Association of serum irisin with metabolic syndrome in obese Chinese adults.
Yan B; Shi X; Zhang H; Pan L; Ma Z; Liu S; Liu Y; Li X; Yang S; Li Z
PLoS One; 2014; 9(4):e94235. PubMed ID: 24709991
[TBL] [Abstract][Full Text] [Related]
18. Irisin levels in the progression of diabetes in sedentary women.
Duran ID; Gülçelik NE; Ünal M; Topçuoğlu C; Sezer S; Tuna MM; Berker D; Güler S
Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637
[TBL] [Abstract][Full Text] [Related]
19. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.
Saadeldin MK; Elshaer SS; Emara IA; Maged M; Abdel-Aziz AK
PLoS One; 2018; 13(11):e0206761. PubMed ID: 30403705
[TBL] [Abstract][Full Text] [Related]
20. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
